We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
APC's partnership with the Coalition for Compounding Excellence continues to grow, with many of our members already signing up. Learn more!
EduCon 2026 brings together some of the sharpest voices in compounding for three live virtual sessions designed around your schedule.
AB 1990 is a Trojan Horse packaged as a patient safety bill. APC is actively fighting it - here's how we're protecting compounders.
Dr. Marty Makary has resigned as FDA Commissioner, with Kyle Diamantas stepping in as acting commissioner. What does that mean for compounding?
An update on state legislation and changes impacting compounding pharmacies – May 8, 2026.
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
